About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Shilpa Medicare to Acquire LOBA Finchemie of Austria

by Medindia Content Team on October 16, 2007 at 8:12 PM
Shilpa Medicare to Acquire LOBA Finchemie of Austria

Shilpa Medicare Ltd. has entered into a memorandum of understanding (MoU) with LOBA Finchemie AG, Austria, to acquire 100 percent shares of LOBA in an all-cash deal. Shilpa is one of India's leading specialty pharmaceutical manufacturers with primary focus on custom synthesis and oncology APIs.

The formal terms will be announced after the due diligence process, currently on, is completed.

Advertisement

Founded in 1957, the privately-owned LOBA provides specialty APIs, organic intermediates, biochemical diagnostics, and customs synthesis. With facilities conforming to top Euro cGMP and USFDA specifications, LOBA counts some of the world's largest pharmaceutical and diagnostic companies as its business partners. The company's product range covers 500 organic compounds available from kilo-to-small ton quantities.

LOBA is a profit-making company, with current annual revenue at nearly 15 million dollars.

LOBA's acquisition, if successful, will fast forward Shilpa Medicare's vision of becoming India's leading manufacturer in the high growth oncology and CRAMS sectors, said Vishnukant Bhutada, Managing Director, Shilpa Medicare.
Advertisement

"LOBA, with its product range, long-standing customer relationships in highly regulated markets, and internationally certified and compliant R&D and manufacturing facilities, is a perfect strategic fit for Shilpa Medicare. Given our highly skilled talent pool and low operational costs, the Shilpa-LOBA combination would be a formidable entity in the global oncology and CRAMS sectors," Bhutada said.

Source: ANI
SRM/V
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Corporate News

 Global Report of Work-related Diseases
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
New AI Tool Could Ensure Smooth Job Transitions
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
 Recent Improvements In Pharmaceutical Sector
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Food to be Covered by Insurance Soon
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharma Companies Have to Support or Risk Damaging Global Reputation
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Shilpa Medicare to Acquire LOBA Finchemie of Austria Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests